The treatment landscape for RR CLL continues to change with the evolution of frontline therapy to include BTKBCL2 inhibitor combinations This Interactive Case Challenge explores the best practices for cytogenetic testing BTK inhibitorassociated resistance mutation testing and selecting optimal therapy from an expansive pool of treatment options following firstline acalabrutinib plus venetoclax
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
97% of listed courses are free
292 of a sample of 300 are free · 545 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Virtual patient / simulation
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJul 31, 2026
-
Last day to claim creditJan 31, 2027 4 months left
-
HealthTree Foundation for Chronic Lymphocytic Leukemia +1 FAST Track to Enhanced CLL Outcomes: Finite Therapy Advances With BTK Inhibitors as New STandards for Frontline Treatment
-
Plexus Communications +1 VHA Oncology Clinical Forums: Optimizing BTK Inhibitor Use in the Management of Veterans With Chronic Lymphocytic Leukemia
-
Global Learning Collaborative Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
-
Clinical Care Options, LLC (dba Decera Clinical Education) Global Perspectives on Sequencing Therapy in Relapsed/Refractory CLL
-
CLL Society +1 Optimizing Patient-Centered Care for Relapsed/Refractory CLL With the Latest Evidence and Guideline Updates: Precision Education With Real-world Insights
-
CLL Society +1 Beyond CIT: Uniting Patient Voices With the Latest Evidence on Novel Targeted Therapies for CLL/SLL
